Several approaches have been proposed to target MMPs as major altered components in the ECM, including genetic methods to reduce MMP-9 overexpression in DMD and stem cell-based transplantation of satellite cells to restore dystrophin [33]. Here, DMD is linked to Duchenne muscular dystrophy.